-
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
Tuesday, November 23, 2021 - 8:17am | 617Read More...According to a German newspaper, Swedish-based investment group EQT and the Struengmann family of Germany are considering a joint move to purchase the Novartis AG's (NYSE: NVS) generics outfit, Sandoz, for $21.6 billion. The price would make it the largest pharma deal of...
-
Top 4 NASDAQ Stocks In The Drugs Generic Industry With The Highest EPS Growth Forecast For Next 5 Years
Monday, December 29, 2014 - 5:33am | 142Read More...Below are the top drugs generic stocks on the NASDAQ in terms of EPS growth forecast for the next five years. Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) earnings per share growth forecast for the next five years is 70.00%. Sagent Pharmaceuticals' PEG ratio is 0.88. Evoke Pharma, Inc. (NASDAQ:...
